ÂÜÀòÂÒÂ×

Warren Mah is a seasoned healthcare executive with extensive experience in leadership roles across various organizations. Currently serving as the Chief Executive Officer at Pathology Asia since September 2022, Warren previously held the position of Vice President at Fresenius Kidney Care for the Asia Pacific region from October 2017 to August 2022, focusing on operational growth and patient care. Prior to that, Warren excelled as CEO of the Primary Care Network in Greater China at ParkwayHealth China from December 2015 to September 2017. Warren's earlier career includes key operational roles at Parkway Pantai Limited and a strategic policy role at the Monetary Authority of Singapore. Warren holds a dual degree in Political Science and Finance from the University of Pennsylvania, obtained between 2002 and 2006.